prednisone has been researched along with Anti-Phospholipid Antibody Syndrome in 93 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with prednisone and aspirin appears to be efficacious, safe, and economic in the prevention of pregnancy loss and fetal growth retardation in patients with aCL." | 7.68 | Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. ( Angel, J; Espinoza, LR; Hubble, CL; Jara, LJ; Martínez-Osuna, P; O'Brien, W; Saway, S; Seleznick, MJ; Silveira, LH, 1992) |
| "All women had suffered from early pregnancy losses and two also had a history of fetal deaths." | 6.82 | Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis. ( Barrio, RD; Cacho, PM; Haya, A; López-Hoyos, M; Lopez-Marin, L; Martínez-Taboada, VM; Riancho-Zarrabeitia, L, 2022) |
| "To assess plasmapheresis with low dose prednisone on obstetric and neonatal outcomes among unsuccessfully treated pregnant women with documented antiphospholipid syndrome (APS)." | 5.12 | Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome. ( El-Foual, FM; El-Haieg, DO; Zanati, MF, 2007) |
| "We compared the use of aspirin alone with combined therapy (prednisone plus aspirin) in antiphospholipid antibody-positive obstetric patients with prior adverse pregnancy outcome." | 5.07 | Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. ( Hobart, JM; MacGregor, SN; Neerhof, MG; Ragin, A; Sholl, JS; Silver, RK, 1993) |
| " Aspirin, prednisone and heparin are most commonly utilized but are not clearly proven to outperform expectant management except in case of antiphospholipid syndrome." | 4.81 | [Medical treatment for recurrent miscarriages]. ( Belaisch-Allart, J; Mayenga, JM, 2002) |
| "Combination therapy with aspirin and heparin may reduce pregnancy loss in women with antiphospholipid antibodies by 54%." | 4.81 | Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. ( Craig, JC; Empson, M; Lassere, M; Scott, JR, 2002) |
| "The management of patients with recurrent miscarriage (RM) and antiphospholipid antibody syndrome (APS) includes prolonged treatment with heparin and aspirin, starting from the confirmation of pregnancy and continuing until 6 weeks after birth." | 3.85 | Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study. ( Chi, HB; Liu, P; Qiao, J; Song, Y; Wang, HY, 2017) |
| "To evaluate health-related quality of life (HRQoL) in primary antiphospholipid syndrome (PAPS) and correlate it with a crude estimate of accrual organ damage, comorbidity (diabetes mellitus, hypertension and dyslipidemia) and treatment (oral anticoagulation, immunosuppressors and prednisone)." | 3.85 | Quality of life in patients with antiphospholipid syndrome is related to disease burden and anticoagulant therapy. ( Cabral, AR; González-Pérez, I; Hernández-Molina, G; Pacheco-Molina, C, 2017) |
| " A successful pregnancy outcome was achieved by combined therapy with aspirin, low-molecular-weight heparin, prednisone, and enzyme replacement therapy with imiglucerase." | 3.71 | Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome. ( Dulitzki, M; Langevitz, P; Levy, Y; Livneh, A; Sherer, Y; Shoenfeld, Y, 2002) |
| "The aim of this study was to determine the neonatal outcome in women with well-characterized antiphospholipid syndrome treated during pregnancy with low-dose aspirin." | 3.69 | Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. ( Balasch, J; Botet, F; Carmona, F; Figueras, J; Montagut, P; Romera, G, 1997) |
| " In 1982, it was suggested for the first time low doses of aspirin and prednisone for treatment of recurrent fetal death associated to this syndrome, heparin therapy was reported in 1984, recommended a doses of 15,000 U/day during first pregnancy trimester and 20,000 U/day posteriorly." | 3.69 | [Recurrent fetal death and antiphospholipid antibody syndrome. A case report]. ( Bustos López, HH; Hernández Andrade, E; Ramírez Peredo, J; Rojas-Poceros, G, 1997) |
| "We reviewed 82 consecutive pregnancies in 54 women with antiphospholipid syndrome who were treated during pregnancy with the following: 1) prednisone and low-dose aspirin; 2) heparin and low-dose aspirin; 3) prednisone, heparin, and low-dose aspirin; or 4) other combinations of these medications or immunoglobulin." | 3.68 | Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. ( Blackwell, JL; Branch, DW; Reading, JC; Scott, JR; Silver, RM, 1992) |
| "Treatment with prednisone and aspirin appears to be efficacious, safe, and economic in the prevention of pregnancy loss and fetal growth retardation in patients with aCL." | 3.68 | Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. ( Angel, J; Espinoza, LR; Hubble, CL; Jara, LJ; Martínez-Osuna, P; O'Brien, W; Saway, S; Seleznick, MJ; Silveira, LH, 1992) |
| "All women had suffered from early pregnancy losses and two also had a history of fetal deaths." | 2.82 | Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis. ( Barrio, RD; Cacho, PM; Haya, A; López-Hoyos, M; Lopez-Marin, L; Martínez-Taboada, VM; Riancho-Zarrabeitia, L, 2022) |
| "Thrombocytopenia is rarely severe, and hemorrhage is far less common than thrombosis." | 2.52 | The significance and management of thrombocytopenia in antiphospholipid syndrome. ( Artim-Esen, B; Diz-Küçükkaya, R; İnanç, M, 2015) |
| "However, when antiphospholipid syndrome is present, its clinical manifestations can be severe and life threatening." | 2.49 | Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature. ( Campomori, F; Ferri, C; Giuggioli, D; Giuggoli, D; Manzini, CU; Schepis, F; Sebastiani, M; Spinella, A; Vacchi, C, 2013) |
| "The risk of preeclampsia and placental insufficiency was substantial and occurred in 50% of patients." | 2.42 | Antiphospholipid syndrome in obstetrics. ( Heilmann, L; Pollow, K; von Tempelhoff, GF, 2003) |
| "Acute respiratory failure (ARF) with diffuse pulmonary infiltrates has been reported in only a few patients with aPL antibodies." | 2.40 | Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome. ( Knoblauch, A; Maggiorini, M; Russi, EW; Schneider, J, 1997) |
| " In the past, attempts to reduce the dosage of glucocorticoids were made using cyclophosphamide, cyclosporin A, mofetil mycophenolate, and their combinations." | 1.72 | [Efficacy of rituximab in minimal change disease, an atypical renal manifestation of antiphospholipid syndrome]. ( Długosz, G; Masajtis-Zagajewska, A; Nowicki, M, 2022) |
| "Autoimmune myelofibrosis is a distinct clinicopathological entity that occurs with autoimmune disorders." | 1.51 | Autoimmune myelofibrosis: a rare haematological involvement in systemic lupus erythematosus. ( Belfeki, N; Declerck, D; Diamantis, S; Shankarasivam, G, 2019) |
| "Vasculitis is usually seen in APS patients with coexistent Systemic Lupus Erythematosus (SLE)." | 1.43 | Cutaneous Vasculitis in a Patient with Antiphospholipid Antibody Syndrome. ( Parke, A; Sheth, K, 2016) |
| "The lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS) - the association of acquired factor II deficiency and lupus anticoagulant - is a rare disease that may cause a predisposition not only to thrombosis but also to severe bleeding." | 1.43 | Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage. ( Bel Feki, N; Ben Ghorbel, I; Houman, MH; Zayet, S, 2016) |
| "Patient 2 presented with a left central retinal vein occlusion without vasculitis but was on anticoagulation therapy due to having an antiphospholipid syndrome." | 1.40 | [Retinal vasculopathy in systemic lupus erythematosus: a case of lupus vasculitis and a case of non-vasculitis venous occlusion]. ( Adán, A; Figueras-Roca, M; Fontenla, JR; Llorens, V; Mesquida, M; Pelegrín, L; Rey, A, 2014) |
| "Antiphospholipid syndrome is an autoimmune disease that presents with recurrent arteriovenous thrombosis, repeated pregnancy loss and elevated titres of antiphospholipid antibodies in the blood." | 1.36 | Antiphospholipid syndrome in childhood systemic lupus erythematosus. ( Paudyal, B, 2010) |
| "Association of celiac disease with systemic lupus erythematosus is rare, even though HLA B8 and DR3 are commonly associated with these diseases." | 1.35 | Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syndrome: a rare association. ( Gupta, D; Mirza, N, 2008) |
| "Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare disorder characterized by a bleeding tendency due to factor II deficiency associated with the presence of lupus anticoagulant (LAC) autoantibodies." | 1.33 | Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome. ( Rich, E; Senécal, JL; Vinet, E, 2006) |
| "Standard treatment for autoimmune hemolytic anemia (AIHA) due to warm antibodies includes combinations of glucocorticoids, immunosuppressive drugs (mainly azathioprine) and splenectomy." | 1.32 | Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome. ( Aguirre, C; Egurbide, MV; Erdozain, JG; Ruiz-Irastorza, G, 2004) |
| "The diagnostic criteria for systemic lupus erythematosus (SLE) were not fulfilled either." | 1.32 | Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome. ( Bladt, V; d'Amore, F; Laursen, B; Petersen, OB; Poulsen, LH; Steengaard-Pedersen, K, 2004) |
| "We report a case of Wegener's granulomatosis (WG) with pulmonary hemorrhage also satisfying the criteria for antiphospholipid antibody syndrome (APS)." | 1.31 | Wegener's granulomatosis associated with antiphospholipid syndrome. ( Castellino, G; La Corte, R; Santilli, D; Trotta, F, 2000) |
| "A diagnosis of mixed connective tissue disease (Sharp-syndrome) was established." | 1.30 | [A patient with mixed collagen disease, antiphospholipid syndrome and Sjögren syndrome]. ( Hartmann, F; Kranzhöfer, N; Lindemuth, R; Zuber, M, 1998) |
| "We report a young woman suffering from systemic lupus erythematosus complicated by severe thrombocytopenia and high-level antiphospholipid antibodies." | 1.30 | [32-year-old patient with systemic lupus erythematosus, thrombocytopenia and ischemic cerebrovascular insult and antiphospholipid antibodies]. ( Demarmels Biasiutti, F; Rigamonti Wermelinger, V, 1999) |
| "Primary antiphospholipid antibody syndrome is rarely complicated by chorea, but should be taken into consideration in patients who do not fulfill the diagnostic criteria for SLE." | 1.29 | Chorea in primary antiphospholipid syndrome. ( Antonini, G; Masala, C; Morino, S; Zangari, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 35 (37.63) | 18.2507 |
| 2000's | 33 (35.48) | 29.6817 |
| 2010's | 21 (22.58) | 24.3611 |
| 2020's | 4 (4.30) | 2.80 |
| Authors | Studies |
|---|---|
| Riancho-Zarrabeitia, L | 1 |
| Lopez-Marin, L | 1 |
| Cacho, PM | 1 |
| López-Hoyos, M | 1 |
| Barrio, RD | 1 |
| Haya, A | 1 |
| Martínez-Taboada, VM | 1 |
| Długosz, G | 1 |
| Masajtis-Zagajewska, A | 1 |
| Nowicki, M | 1 |
| Schmelz, JL | 1 |
| Navsaria, L | 1 |
| Goswamy, R | 1 |
| Chuang, HH | 1 |
| Miranda, RN | 1 |
| Lee, HJ | 1 |
| Meng, J | 1 |
| Chen, L | 1 |
| Hou, J | 1 |
| Chi, H | 1 |
| Wang, Z | 1 |
| Yang, C | 1 |
| Su, Y | 1 |
| Ye, SL | 1 |
| Gu, XK | 1 |
| Tao, LY | 1 |
| Cong, JM | 1 |
| Wang, YQ | 1 |
| Belfeki, N | 1 |
| Shankarasivam, G | 1 |
| Declerck, D | 1 |
| Diamantis, S | 1 |
| Sebastiani, M | 1 |
| Manzini, CU | 1 |
| Campomori, F | 1 |
| Spinella, A | 1 |
| Vacchi, C | 1 |
| Giuggioli, D | 1 |
| Giuggoli, D | 1 |
| Schepis, F | 1 |
| Ferri, C | 1 |
| Figueras-Roca, M | 1 |
| Rey, A | 1 |
| Mesquida, M | 1 |
| Pelegrín, L | 1 |
| Llorens, V | 1 |
| Fontenla, JR | 1 |
| Adán, A | 1 |
| Revaux, A | 1 |
| Mekinian, A | 1 |
| Nicaise, P | 1 |
| Bucourt, M | 1 |
| Cornelis, F | 1 |
| Lachassinne, E | 1 |
| Chollet-Martin, S | 1 |
| Fain, O | 2 |
| Carbillon, L | 1 |
| Artim-Esen, B | 1 |
| Diz-Küçükkaya, R | 1 |
| İnanç, M | 1 |
| Elera-Fitzcarrald, C | 1 |
| Alfaro-Lozano, JL | 1 |
| Pastor-Asurza, CA | 1 |
| Sheth, K | 1 |
| Parke, A | 1 |
| Bel Feki, N | 1 |
| Zayet, S | 1 |
| Ben Ghorbel, I | 1 |
| Houman, MH | 1 |
| Zen, M | 1 |
| Iaccarino, L | 1 |
| Gatto, M | 1 |
| Bettio, S | 1 |
| Saccon, F | 1 |
| Ghirardello, A | 1 |
| Punzi, L | 1 |
| Doria, A | 1 |
| Song, Y | 1 |
| Wang, HY | 1 |
| Qiao, J | 1 |
| Liu, P | 1 |
| Chi, HB | 1 |
| Hernández-Molina, G | 1 |
| González-Pérez, I | 1 |
| Pacheco-Molina, C | 1 |
| Cabral, AR | 1 |
| Appenzeller, S | 2 |
| Vinet, E | 2 |
| Clarke, A | 1 |
| Ishaq, S | 1 |
| Khalil, S | 1 |
| Khan, A | 1 |
| Khalid, U | 1 |
| Prado, DM | 1 |
| Gualano, B | 1 |
| Pinto, AL | 1 |
| Sallum, AM | 1 |
| Perondi, MB | 1 |
| Roschel, H | 1 |
| Silva, CA | 1 |
| Paudyal, B | 1 |
| Bonar, R | 1 |
| Favaloro, E | 1 |
| Zebeljan, D | 1 |
| Rosenfeld, D | 1 |
| Kershaw, G | 1 |
| Mohammed, S | 1 |
| Marsden, K | 1 |
| Hertzberg, M | 1 |
| Noaiseh, G | 1 |
| Bhangle, S | 1 |
| Vivino, F | 1 |
| Kovács, M | 1 |
| Hartwig, M | 1 |
| Aleksza, M | 1 |
| Tihanyi, M | 1 |
| Nagy, T | 1 |
| Vajda, G | 1 |
| Daru, J | 1 |
| Gasztonyi, B | 1 |
| Yazbek, MA | 1 |
| Velho, P | 1 |
| Nadruz, W | 1 |
| Mahayri, N | 1 |
| Costallat, LT | 1 |
| Paschal, RD | 1 |
| Neff, AT | 1 |
| Liu, XL | 1 |
| Xiao, J | 1 |
| Zhu, F | 1 |
| Belaisch-Allart, J | 1 |
| Mayenga, JM | 1 |
| Salazar-Páramo, M | 1 |
| Jara, LJ | 2 |
| Ramos, A | 1 |
| Barile, L | 1 |
| Machado, G | 1 |
| García-De La Torre, I | 1 |
| Sinnreich, M | 1 |
| Rossillion, B | 1 |
| Landis, T | 1 |
| Burkhard, PR | 1 |
| Sztajzel, R | 1 |
| Heilmann, L | 1 |
| von Tempelhoff, GF | 1 |
| Pollow, K | 1 |
| Ruiz-Irastorza, G | 2 |
| Khamashta, MA | 1 |
| Hughes, GR | 1 |
| Mertens, D | 1 |
| Martin, L | 1 |
| Armingaud, P | 1 |
| Georgescu, V | 1 |
| Matre, F | 1 |
| Legac, E | 1 |
| Estève, E | 1 |
| Hadjigogos, K | 1 |
| Marinaki, P | 1 |
| Sellami, M | 1 |
| Elloumi, M | 1 |
| Fourati, H | 1 |
| Ayadi, N | 1 |
| Baklouti, S | 1 |
| Suárez Ortega, S | 1 |
| Campos-Herrero Navas, MI | 1 |
| Limeres González, MA | 1 |
| Díaz López, F | 1 |
| Zarzalejos Andes, JM | 1 |
| Arkuch Saade, ME | 1 |
| Alijotas-Reig, J | 1 |
| Ferrer-Raventos, JC | 1 |
| Wisløff, F | 1 |
| Crowther, M | 1 |
| Erdozain, JG | 1 |
| Egurbide, MV | 1 |
| Aguirre, C | 1 |
| Bladt, V | 1 |
| Steengaard-Pedersen, K | 1 |
| Poulsen, LH | 1 |
| Petersen, OB | 1 |
| Laursen, B | 1 |
| d'Amore, F | 1 |
| Durukan, AH | 1 |
| Akar, Y | 1 |
| Bayraktar, MZ | 1 |
| Dinc, A | 1 |
| Sahin, OF | 1 |
| Veneri, D | 1 |
| Ambrosetti, A | 1 |
| Franchini, M | 1 |
| Mosna, F | 1 |
| Poli, G | 1 |
| Pizzolo, G | 1 |
| Rich, E | 1 |
| Senécal, JL | 1 |
| Bobrowska-Snarska, D | 1 |
| Ostanek, L | 1 |
| Nesterowicz, B | 1 |
| Brzosko, M | 1 |
| Kornacka, MK | 1 |
| Bokiniec, R | 1 |
| Elchalal, U | 1 |
| Gabbay, E | 1 |
| Nadjari, M | 1 |
| Varon, D | 1 |
| Zelig, O | 1 |
| Ben-Chetrit, E | 1 |
| Cavallasca, JA | 1 |
| Laborde, HA | 1 |
| Ruda-Vega, H | 1 |
| Nasswetter, GG | 1 |
| El-Haieg, DO | 1 |
| Zanati, MF | 1 |
| El-Foual, FM | 1 |
| Erre, GL | 1 |
| Pardini, S | 1 |
| Faedda, R | 1 |
| Passiu, G | 1 |
| Gupta, D | 1 |
| Mirza, N | 1 |
| Harris, EN | 1 |
| Mathieu, E | 1 |
| Seror, O | 1 |
| Ganne, N | 1 |
| Aurousseau, MH | 1 |
| Coderc, E | 1 |
| Sitbon, M | 1 |
| Thomas, M | 1 |
| Vlachoyiannopoulos, PG | 1 |
| Tsiakou, E | 1 |
| Chalevelakis, G | 1 |
| Raptis, SA | 1 |
| Moutsopoulos, HM | 1 |
| Dubost, JJ | 1 |
| Kémény, JL | 1 |
| Soubrier, M | 1 |
| Guélon, D | 1 |
| Bommelaer, G | 1 |
| Amouroux, J | 1 |
| Sauvezie, B | 1 |
| Fletcher, HM | 1 |
| Wharfe, GH | 1 |
| Thomas, E | 1 |
| Ruiz-Argüelles, GJ | 1 |
| Ruiz-Argüelles, A | 1 |
| Pérez-Romano, B | 1 |
| Alarcón-Segovia, D | 2 |
| Silver, RK | 1 |
| MacGregor, SN | 1 |
| Sholl, JS | 1 |
| Hobart, JM | 1 |
| Neerhof, MG | 1 |
| Ragin, A | 1 |
| Sagot, P | 1 |
| Fiks-Sigaud, M | 1 |
| Audrain, M | 1 |
| Muller, JY | 1 |
| Menashe, Y | 1 |
| Ben-Baruch, G | 1 |
| Greenspoon, JS | 1 |
| Carp, HJ | 1 |
| Rosen, DJ | 1 |
| Mashiach, S | 1 |
| Many, A | 1 |
| Marco, P | 1 |
| Lucas, J | 1 |
| Alonso, A | 1 |
| Pérez Vázquez, J | 1 |
| Fernández, P | 1 |
| Victoria, C | 1 |
| García, MC | 1 |
| Calatayud, R | 1 |
| Keung, YK | 1 |
| Cobos, E | 1 |
| Meyerrose, GE | 1 |
| Roberson, GH | 1 |
| Van Horn, G | 1 |
| Arnett, FC | 1 |
| Dimachkie, MM | 1 |
| Castle, SP | 1 |
| Mather-Mondrey, M | 1 |
| Bennion, S | 1 |
| David-Bajar, K | 1 |
| Huff, C | 1 |
| Masala, C | 1 |
| Morino, S | 1 |
| Zangari, P | 1 |
| Antonini, G | 1 |
| Reece, EA | 2 |
| Garofalo, J | 1 |
| Zheng, XZ | 1 |
| Assimakopoulos, E | 1 |
| Cockwell, P | 1 |
| Maggiorini, M | 1 |
| Knoblauch, A | 1 |
| Schneider, J | 1 |
| Russi, EW | 1 |
| Hachulla, E | 1 |
| Botet, F | 1 |
| Romera, G | 1 |
| Montagut, P | 1 |
| Figueras, J | 1 |
| Carmona, F | 1 |
| Balasch, J | 1 |
| Ware, AE | 1 |
| Mongey, AB | 1 |
| Rojas-Poceros, G | 1 |
| Ramírez Peredo, J | 1 |
| Hernández Andrade, E | 1 |
| Bustos López, HH | 1 |
| Zuber, M | 1 |
| Kranzhöfer, N | 1 |
| Lindemuth, R | 1 |
| Hartmann, F | 1 |
| Monastiri, K | 1 |
| Chaieb, A | 1 |
| Skouri, H | 1 |
| Slama, A | 1 |
| Chebil, S | 1 |
| Maaroufi, R | 1 |
| Nouira, M | 1 |
| Mokni, M | 1 |
| Zanina, R | 1 |
| Saidi, H | 1 |
| Ben Amor, F | 1 |
| Bibi, M | 1 |
| Mahjoub, T | 1 |
| Kortas, M | 1 |
| Snoussi, N | 1 |
| Khairi, H | 1 |
| Wiechens, B | 1 |
| Schröder, JO | 1 |
| Pötzsch, B | 1 |
| Rochels, R | 1 |
| Tam, LS | 1 |
| Li, EK | 1 |
| Angelini, L | 1 |
| Granata, T | 1 |
| Zibordi, F | 1 |
| Binelli, S | 1 |
| Zorzi, G | 1 |
| Besana, C | 1 |
| Cowchock, S | 1 |
| Cantalapiedra, A | 1 |
| Avello, AG | 1 |
| Navarro, JL | 1 |
| Cesar, JM | 1 |
| Stefani, PM | 1 |
| Pietrogrande, F | 1 |
| Sartori, R | 1 |
| Girolami, A | 1 |
| Rigamonti Wermelinger, V | 1 |
| Demarmels Biasiutti, F | 1 |
| Canales, MA | 1 |
| Sevilla, J | 1 |
| Hernández, D | 1 |
| Hernández Navarro, F | 1 |
| Singh, AK | 1 |
| Castellino, G | 1 |
| La Corte, R | 1 |
| Santilli, D | 1 |
| Trotta, F | 1 |
| Yacobovich, JR | 1 |
| Uziel, Y | 1 |
| Friedman, Z | 1 |
| Radnay, J | 1 |
| Wolach, B | 1 |
| Stratta, P | 1 |
| Canavese, C | 1 |
| Santi, S | 1 |
| Ciccone, G | 1 |
| Rosso, S | 1 |
| Fiehn, C | 1 |
| Breitbart, A | 1 |
| Germann, G | 1 |
| Beşbaş, N | 1 |
| Anlar, B | 1 |
| Apak, A | 1 |
| Kansu, T | 1 |
| Empson, M | 1 |
| Lassere, M | 1 |
| Craig, JC | 1 |
| Scott, JR | 2 |
| Sherer, Y | 1 |
| Dulitzki, M | 1 |
| Levy, Y | 1 |
| Livneh, A | 1 |
| Shoenfeld, Y | 1 |
| Langevitz, P | 1 |
| Branch, DW | 2 |
| Silver, RM | 1 |
| Blackwell, JL | 1 |
| Reading, JC | 1 |
| Silveira, LH | 1 |
| Hubble, CL | 1 |
| Saway, S | 1 |
| Martínez-Osuna, P | 1 |
| Seleznick, MJ | 1 |
| Angel, J | 1 |
| O'Brien, W | 1 |
| Espinoza, LR | 1 |
| Sánchez-Guerrero, J | 1 |
| Cowchock, FS | 1 |
| Balaban, D | 1 |
| Plouffe, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)[NCT03152058] | Phase 2 | 55 participants (Anticipated) | Interventional | 2017-05-17 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for prednisone and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis.
Topics: Abortion, Spontaneous; Antiphospholipid Syndrome; Cohort Studies; Diabetes, Gestational; Female; Fet | 2022 |
Probable catastrophic antiphospholipid syndrome secondary to chronic myelomonocytic leukaemia in an adult patient and a mini review.
Topics: Antiphospholipid Syndrome; Bone Marrow; Computed Tomography Angiography; Humans; Hydroxychloroquine; | 2020 |
Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature.
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Azathioprine; Budd-Chiari Syndrome; Comorbi | 2013 |
The significance and management of thrombocytopenia in antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Prednisone; Thromb | 2015 |
Resolution of Hypoprothrombinemia-Lupus Anticoagulant Syndrome (HLAS) after multidrug therapy with rituximab: a case report and review of the literature.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antiphospholipid Syndrome; Drug Therapy, Combination; | 2013 |
[Medical treatment for recurrent miscarriages].
Topics: Abortion, Habitual; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulant | 2002 |
Antiphospholipid syndrome in obstetrics.
Topics: Abortion, Habitual; Abortion, Spontaneous; Adult; Annexin A5; Antibodies, Anticardiolipin; Anticoagu | 2003 |
Treatment of pregnancy loss in Hughes syndrome: a critical update.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; Heparin; H | 2002 |
Antibody-mediated thrombosis and pregnancy loss.
Topics: Abortion, Spontaneous; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination | 2003 |
Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure.
Topics: Abortion, Habitual; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Ev | 2004 |
[Newborn from mother with antiphospholipid syndrome].
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; beta 2-Glycoprotein I; Female; Fet | 2006 |
Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature.
Topics: Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antico | 2008 |
Diagnosis and management of antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Cyclophosphamide; Diagnosis, Differential; Drug Th | 1994 |
[Primary antiphospholipid syndrome of fatal course and osteoarticular cytosteatonecrosis].
Topics: Antiphospholipid Syndrome; Fat Necrosis; Fatal Outcome; Humans; Injections, Jet; Male; Middle Aged; | 1994 |
[Antiphospholipid syndrome. Proposition for management].
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Immunoglobulins, Intravenous; Mass Scre | 1993 |
Progressive thrombosis after treatment of diffuse large cell non-Hodgkin's lymphoma and concomitant lupus anticoagulant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Cyclophosphamide; | 1996 |
Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Humans; Lung; Male; Methylprednisolone; Midd | 1997 |
Treatment of antiphospholipid syndrome in pregnancy.
Topics: Abortion, Habitual; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anticoagulants; Antiphospholi | 1998 |
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 2002 |
5 trials available for prednisone and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Female; Humans; Live | 2007 |
Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients.
Topics: Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; F | 1993 |
[Antiphospholipid antibodies in women with habitual abortions. Treatment with prednisone and acetylsalicylic acid during pregnancy].
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Drug Th | 1995 |
Partial seizures associated with antiphospholipid antibodies in childhood.
Topics: Adolescent; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticonvulsants; Antiphosphol | 1998 |
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.
Topics: Abortion, Habitual; Antiphospholipid Syndrome; Female; Fetal Membranes, Premature Rupture; Heparin; | 1992 |
69 other studies available for prednisone and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
[Efficacy of rituximab in minimal change disease, an atypical renal manifestation of antiphospholipid syndrome].
Topics: Adult; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Anticoagulants; Antiphospholipid Syndro | 2022 |
Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Cyclophosphamide; D | 2020 |
Efficacy of Different Treatment Regimens for Antiphospholipid Syndrome-related Recurrent Spontaneous Abortion.
Topics: Abortion, Habitual; Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Birt | 2017 |
Autoimmune myelofibrosis: a rare haematological involvement in systemic lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Antirheumatic Agents; Autoimmune Disease | 2019 |
[Retinal vasculopathy in systemic lupus erythematosus: a case of lupus vasculitis and a case of non-vasculitis venous occlusion].
Topics: Acenocoumarol; Antibodies, Monoclonal, Murine-Derived; Anticoagulants; Antiphospholipid Syndrome; Ca | 2014 |
Antiphospholipid syndrome and other autoimmune diseases associated with chronic intervillositis.
Topics: Adult; Antiphospholipid Syndrome; Autoantibodies; Autoimmune Diseases; Chorionic Villi; Chronic Dise | 2015 |
Garre's sclerosing osteomyelitis caused by salmonella group D in a patient with systemic lupus erythematosus: an unusual complication.
Topics: Adult; Anti-Bacterial Agents; Antiphospholipid Syndrome; Ceftazidime; Doxycycline; Femur; Humans; Hy | 2015 |
Cutaneous Vasculitis in a Patient with Antiphospholipid Antibody Syndrome.
Topics: Antiphospholipid Syndrome; Biopsy; Common Cold; Female; Glucocorticoids; Humans; Middle Aged; Predni | 2016 |
Lupus anticoagulant-hypoprothrombinemia syndrome presenting with co-existing cerebral venous thrombosis and subdural hemorrhage.
Topics: Adult; Antiphospholipid Syndrome; Cerebral Veins; Female; Hematoma, Subdural; Humans; Hypoprothrombi | 2016 |
The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients.
Topics: Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Disease-Free Survival; Female; Follow-Up | 2017 |
Antiphospholipid Antibody Titers and Clinical Outcomes in Patients with Recurrent Miscarriage and Antiphospholipid Antibody Syndrome: A Prospective Study.
Topics: Abortion, Habitual; Adult; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; | 2017 |
Quality of life in patients with antiphospholipid syndrome is related to disease burden and anticoagulant therapy.
Topics: Administration, Oral; Adult; Anticoagulants; Antiphospholipid Syndrome; Blood Coagulation; Case-Cont | 2017 |
Disseminated herpes zoster causing extensive skin necrosis.
Topics: Acyclovir; Antiphospholipid Syndrome; Antiviral Agents; Drug Therapy, Combination; Female; Herpes Zo | 2009 |
Chorea as an unusual presenting feature of anti-phospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Chorea; Diagnosis, Differential; Humans; Lupus Erythematosus, Sy | 2010 |
Exercise in a child with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adolescent; Anaerobic Threshold; Antiphospholipid Syndrome; Azathioprine; Drug Therapy, Combination; | 2011 |
Antiphospholipid syndrome in childhood systemic lupus erythematosus.
Topics: Adolescent; Antihypertensive Agents; Antiphospholipid Syndrome; Female; Glucocorticoids; Heparin; Hu | 2010 |
Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antiphospholipid Syndrome; Blood Coagulation Tests; Cl | 2012 |
Idiopathic mediastinal fibrosis presenting with antiphospholipid antibody syndrome and manifestations suggestive of connective tissue disease.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Antirheumatic Agents; Azathioprine; Connecti | 2012 |
Antiphospholipid antibodies in relation to sterility/infertility.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Female; Follow-Up Studies; | 2012 |
Extensive skin necrosis induced by low-molecular-weight heparin in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Eruptions; Drug Therapy, Combination; Enoxaparin; Female; F | 2012 |
Anti-β2 glycoprotein I antibodies and pregnancy outcome in antiphospholipid syndrome.
Topics: Adult; Antibodies; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Fe | 2013 |
Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Antiphospholipid Syndrome; Biomarkers; | 2002 |
Bilateral optic ischemic neuropathy related to chronic hepatitis C-associated anticardiolipin antibodies.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Cardiolipins; Diabetes Mellitus; Diagnosis, | 2003 |
Acute bullous purpura associated with hyperhomocysteinemia and antiphospholipid antibodies.
Topics: Acute Disease; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Biopsy, Needle; Female | 2003 |
Autoimmune hepatitis and the antiphospholipid antibody syndrome. A case report.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Pred | 2003 |
[Combined hypoprothrombinemia-antiphospholipid syndrome in a patient suffering from lupus].
Topics: Adult; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Glucocorticoids; Humans; Hypoprothrombin | 2004 |
[Invasive infection by Aspergillus terreus treated successfully with liposomal amphotericin B].
Topics: Aged; Amphotericin B; Antifungal Agents; Antiphospholipid Syndrome; Aspergillosis; Aspergillus; Auto | 2004 |
Life-threatening bleeding, pregnancy and lupus anticoagulant: success after steroid and anticoagulant therapy.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Glucocorticoids; | 2004 |
Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antip | 2004 |
Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome.
Topics: Abortion, Habitual; Activated Protein C Resistance; Adult; Anticoagulants; Antiphospholipid Syndrome | 2004 |
Combined retinal artery and vein occlusion in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Female; Fluorescein Angiography; Glucocorticoids; Humans; Lupus Er | 2005 |
Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anticoagulants; Antineoplastic Combi | 2005 |
Thromboembolism complicating the treatment of lupus anticoagulant hypoprothrombinemia syndrome.
Topics: Adrenal Cortex Hormones; Antiphospholipid Syndrome; Azathioprine; Central Nervous System Diseases; C | 2006 |
[Severe neurological and obstetrical complications in a patient with antiphospholipid syndrome].
Topics: Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Fe | 2006 |
Catastrophic antiphospholipid syndrome in the second trimester of pregnancy.
Topics: Abortion, Induced; Adult; Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents, Hormonal; | 2006 |
Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE).
Topics: Adult; Antiphospholipid Syndrome; Argentina; Comorbidity; Female; Humans; Infant, Low Birth Weight; | 2008 |
Systemic lupus erythematosus, celiac disease and antiphospholipid antibody syndrome: a rare association.
Topics: Adult; Antiphospholipid Syndrome; Antirheumatic Agents; Celiac Disease; Diet, Gluten-Free; Female; H | 2008 |
Aortitis: a new manifestation of primary antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aortitis; Humans; Male; Middle Aged; Prednisone; Tomography, X-Ray Comput | 1995 |
Antiphospholipid syndrome: clinical and therapeutic aspects.
Topics: Adolescent; Adult; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Female; Hum | 1994 |
Successful pregnancies in patients with antiphospholipid syndrome treated with low-dose aspirin.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Heparin; Humans; Methy | 1993 |
Protein S deficiency associated to anti-protein S antibodies in a patient with mixed connective-tissue disease and its reversal by danazol.
Topics: Adult; Antiphospholipid Syndrome; Autoantibodies; Connective Tissue Diseases; Danazol; Female; Human | 1993 |
Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Heparin; | 1993 |
Reversible dementia and chorea in a young woman with the lupus anticoagulant.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Chorea; Dementia; Depression; Diagno | 1996 |
Chronic herpes gestationis and antiphospholipid antibody syndrome successfully treated with cyclophosphamide.
Topics: Adult; Antiphospholipid Syndrome; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressi | 1996 |
Chorea in primary antiphospholipid syndrome.
Topics: Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipi | 1996 |
Pregnancy outcome. Influence of antiphospholipid antibody titer, prior pregnancy losses and treatment.
Topics: Abortion, Spontaneous; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Aspirin; Fema | 1997 |
Systemic lupus erythematosus [clinical inference].
Topics: Adult; Antiphospholipid Syndrome; Azathioprine; Cyclophosphamide; Female; Humans; Lupus Erythematosu | 1997 |
Arthritis and primary antiphospholipid syndrome.
Topics: Antibodies, Antinuclear; Antiphospholipid Syndrome; Arthritis; Humans; Lupus Erythematosus, Systemic | 1997 |
Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy.
Topics: Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; As | 1997 |
Lupus and cerebrovascular accidents.
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Autoimmune Diseases; | 1997 |
[Recurrent fetal death and antiphospholipid antibody syndrome. A case report].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiphospholipid Syndrome; | 1997 |
[A patient with mixed collagen disease, antiphospholipid syndrome and Sjögren syndrome].
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Azathioprine; Biopsy; Diagnosis, Differential; Drug Thera | 1998 |
[Primary antiphospholipid syndrome in obstetrics. Apropos of 4 cases with fetal survival].
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dipyridamole; D | 1996 |
Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy.
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Drug Therapy, Combinatio | 1997 |
Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Cyclophosphamide; Diltiazem; Female; Humans; Hyper | 1998 |
Familial occurrence of primary antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Autoantibodies; Family Health; Female; Follow-Up Studies; Humans; | 1999 |
Immunosuppression due to MACOP-B does not seem to cure the antiphospholipid syndrome.
Topics: Adult; Antibodies, Antinuclear; Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syn | 1999 |
[32-year-old patient with systemic lupus erythematosus, thrombocytopenia and ischemic cerebrovascular insult and antiphospholipid antibodies].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Brain Infarction; Drug Therapy, Combination; Fatal | 1999 |
[Efficacy of the combined treatment with immunoglobulins and plasmapheresis in a pregnant woman with Rh alloimmunization and antiphospholipid antibodies].
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Combined Modality Therapy; Female; Fibrinolytic Agents; H | 1999 |
Lupus nephritis and the anti-phospholipid antibody syndrome in pregnancy.
Topics: Abortion, Induced; Adult; Antiphospholipid Syndrome; Cyclophosphamide; Female; Glucocorticoids; Huma | 2000 |
Wegener's granulomatosis associated with antiphospholipid syndrome.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Anticoagulants; Antiphospho | 2000 |
Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome.
Topics: Antiphospholipid Syndrome; Child; Diagnosis, Differential; Female; Hemorrhage; Humans; Lupus Coagula | 2001 |
Systemic lupus erythematosus.
Topics: Antiphospholipid Syndrome; Azathioprine; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunogl | 2001 |
Autologous skin transplantation for widespread cutaneous necrosis in secondary antiphospholipid syndrome.
Topics: Adult; Antiphospholipid Syndrome; Cyclosporine; Dermatologic Surgical Procedures; Female; Humans; Im | 2001 |
Optic neuropathy in primary antiphospholipid syndrome in childhood.
Topics: Antiphospholipid Syndrome; Child; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Admini | 2001 |
Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Gauche | 2002 |
Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; H | 1992 |
Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin.
Topics: Abortion, Spontaneous; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aspirin; Enzym | 1992 |
Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients.
Topics: Adult; Antibodies; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Female; Hum | 1992 |